UNSPSC 85816105: Introduction of anti-inflammatory into peripheral nerves and plexi, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of anti-inflammatory into peripheral nerves and plexi, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0T33Z

UNSPSC 85816105 Introduction of anti-inflammatory into peripheral nerves and plexi, percutaneous approach is a Commodity code with minimal alignment to current state and local procurement activity. The recent opportunities block shows no substantive match between the code's medical procedure scope and the solicitations posted under it.

The opportunities tagged to this code span telehealth urgent care, nursing home operations, occupational health services, cancer screening, retinal imaging devices, EMS staffing, employee health clinics, medical directorships, psychological evaluation, wellness platforms, recovery audit contracting, substance use treatment, and related behavioral and occupational health services across multiple states and issuing bodies including health authorities, counties, cities, school districts, and health systems. None of these solicitations describe percutaneous anti-inflammatory injection into peripheral nerves or plexi—a highly specialized interventional pain management or neurology procedure. The code appears to have been applied broadly or inconsistently by state and local procurement offices to capture general healthcare services rather than the specific procedure the Commodity code describes. Given the absence of relevant recent opportunities, this code shows little decision-relevant procurement signal for vendors offering peripheral nerve or plexus anti-inflammatory injection services to state and local buyers.